Chronic O2 exposure in the newborn rat results in decreased pulmonary arterial nitric oxide release and altered smooth muscle response to isoprostane.
about
Developmental changes in arginase expression and activity in the lungPerinatal factors in neonatal and pediatric lung diseasesSildenafil improves alveolar growth and pulmonary hypertension in hyperoxia-induced lung injury.Oxygen toxicity and reactive oxygen species: the devil is in the details.Bronchopulmonary dysplasia early changes leading to long-term consequences.L-citrulline attenuates arrested alveolar growth and pulmonary hypertension in oxygen-induced lung injury in newborn rats.Pulmonary hemodynamics and vascular reactivity in asphyxiated term lambs resuscitated with 21 and 100% oxygenPulmonary arterial contractility in neonatal lambs increases with 100% oxygen resuscitationSuperoxide dismutase improves oxygenation and reduces oxidation in neonatal pulmonary hypertension.Altered vasoreactivity in neonatal rats with pulmonary hypertension associated with bronchopulmonary dysplasia: Implication of both eNOS phosphorylation and calcium signalingIsoprostanes as physiological mediators of transition to newborn life: novel mechanisms regulating patency of the term and preterm ductus arteriosus.Isoprostanes and lung vascular pathology.NADPH oxidases and reactive oxygen species at different stages of chronic hypoxia-induced pulmonary hypertension in newborn piglets.Oxygen concentration and pulmonary hemodynamics in newborn lambs with pulmonary hypertension.Regulation of the pulmonary circulation in the fetus and newborn.Considerations in the management of hypoxemic respiratory failure and persistent pulmonary hypertension in term and late preterm neonates.The Fetus Can Teach Us: Oxygen and the Pulmonary Vasculature.Oxygen dose responsiveness of human fetal airway smooth muscle cells.Maternal-pup interaction disturbances induce long-lasting changes in the newborn rat pulmonary vasculature.Acute vasodilator effects of Rho-kinase inhibitors in neonatal rats with pulmonary hypertension unresponsive to nitric oxide.Management of Supplemental Oxygen for Infants with Persistent Pulmonary Hypertension of Newborn: A Survey.
P2860
Q28579809-0641952B-1C62-45FC-9B49-F4B36C66AF6BQ33945932-978981C5-F1D9-4E2D-A10F-778A94B8277CQ34558395-8CAC7F89-2C20-42D6-85E6-1A027C165C84Q34977549-26AFE2B2-1329-4F81-AB48-A9A404D98029Q35077309-0A70F84C-EC6F-474B-8D08-3C1BC5C130D6Q35093512-6B6E40B4-E078-47C8-945C-5A8E1D0E473FQ35562030-BDA524AA-21FF-4CA7-83A7-505C5F4B46B7Q36169607-31339391-E84E-431A-8436-1F6A8D847FC9Q36202749-1C636BE6-9177-4DBA-8243-9EA17020DD07Q36290314-38EF2813-4FE9-473E-9EFA-FA5CEB30E39DQ36650599-35DB6BF7-ED39-469A-97BC-CC07EBE6083FQ37149206-A8D7B539-FF78-4F88-804B-A47E6441EB33Q37406398-267A182F-CCA2-4F00-BBE9-A5D384251C53Q37436986-BF9EBBD2-BAE5-4C34-AF06-B9FF0A626A58Q37801516-9325EB39-6E0D-4860-8124-AA4EE7645B3EQ38844478-6432D17D-0C01-40E9-ACAB-9AA934EB329EQ41552506-842FAA3A-180E-475F-8969-42DF0C33B03DQ42091881-4B0E3F76-A6EB-4810-A978-3D7D2DC92552Q46674014-098655C9-957E-4F6C-8FF7-9EDA918E4B77Q46886439-E7B68F2F-68F5-48AA-86E9-639F1614FA6AQ49205996-596125D0-F285-41D1-A76D-F42C097F235C
P2860
Chronic O2 exposure in the newborn rat results in decreased pulmonary arterial nitric oxide release and altered smooth muscle response to isoprostane.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
2003年學術文章
@zh-hant
name
Chronic O2 exposure in the new ...... uscle response to isoprostane.
@en
Chronic O2 exposure in the new ...... uscle response to isoprostane.
@nl
type
label
Chronic O2 exposure in the new ...... uscle response to isoprostane.
@en
Chronic O2 exposure in the new ...... uscle response to isoprostane.
@nl
prefLabel
Chronic O2 exposure in the new ...... uscle response to isoprostane.
@en
Chronic O2 exposure in the new ...... uscle response to isoprostane.
@nl
P2093
P2860
P1476
Chronic O2 exposure in the new ...... uscle response to isoprostane.
@en
P2093
P2860
P304
P356
10.1152/JAPPLPHYSIOL.00825.2003
P407
P577
2003-10-17T00:00:00Z